Institute for Clinical & Economic Review Issues Report Entitled 'Aducanumab for Alzheimer's Disease: Effectiveness and Value'

Press/Media: Expert Comment

PeriodSep 14 2021

Media coverage

1

Media coverage

  • TitleInstitute for Clinical & Economic Review Issues Report Entitled 'Aducanumab for Alzheimer's Disease: Effectiveness and Value'
    Media name/outletTargeted News Service
    Country/TerritoryUnited States
    Date9/14/21
    PersonsDenver Whittington